Rishi Bhattacharjee

Rishi Bhattacharjee has extensive work experience in the pharmaceutical industry, holding various leadership roles in quality assurance and compliance. Rishi is currently the Vice President of Clinical Quality Assurance at Mersana Therapeutics since April 2023. Prior to that, they worked as the Vice President at NOVAVAX INC from January 2021 to May 2023. Rishi also served as the Sr. Director, Head of Global Quality Management at Otsuka Pharmaceutical Development & Commercialization Inc from January 2020 to January 2021. Before that, they held the position of Sr. Director Global Head GxP Audits at Daiichi Sankyo, Inc. from February 2017 to January 2020. Rishi's extensive background in quality assurance and compliance began at Eisai Inactive Page, where they worked as the Sr. Director of Clinical Quality Assurance and Compliance from January 2005 to January 2017. In this role, they led a team of auditors and analysts and ensured the highest standards of compliance for clinical studies.

Rishi Bhattacharjee completed their Higher Secondary education from Patha Bhavan between 1983 and 1985. Prior to that, they completed their School Finals from Ramkrishna Mission Narendrapur from 1977 to 1983. Rishi later pursued a Master of Science degree in Mechanical Engineering from the University of Mississippi. Apart from their formal education, there is no information available regarding any additional certifications or qualifications.